Original Article
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 28, 2014; 20(48): 18240-18248
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18240
Table 5 Marker expression in relation to tumor stage and grade n (%)
GeneStage
Grade
Early (n = 18)Late (n = 52)P valueLow (n = 43)High (n = 27)P value
Telomerase+++2 (11.11)24 (46.15)0.0198 (18.60)18 (66.67)< 0.001
++6 (33.33)7 (13.46)11 (25.58)2 (7.41)
-10 (55.56)21 (40.37)24 (55.81)7 (25.93)
MAGE1+++0 (0.00)9 (17.31)0.0993 (6.98)6 (22.22)0.123
++8 (44.44)25 (48.08)20 (46.51)13 (48.15)
-10 (55.56)18 (34.62)20 (46.51)8 (29.63)
MAGE3+++2 (11.11)22 (42.31)< 0.0016 (13.95)18 (66.67)< 0.001
++13 (72.22)7 (13.46)19 (44.19)1 (3.70)
-3 (16.67)23 (44.23)18 (41.86)8 (29.63)
CD133+0 (0.00)28 (53.85)< 0.0019 (20.93)19 (70.37)< 0.001
-18 (100.00)24 (46.15)34 (79.07)8 (29.63)
CK19+10 (55.56)52 (100.00)< 0.00135 (81.40)27 (100.00)< 0.017
-8 (44.44)0 (0.00)8 (18.60)0 (0.00)
CD90+6 (33.30)31 (59.60)0.0159 (20.93)19 (70.37)< 0.001
-12 (66.70)11 (21.15)34 (79.07)8 (29.63)